Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle

Ahmad Boota, Bruce Johnson, Kee L. Lee, Michelle A. Blaskovich, Shang Xi Liu, Valerian E. Kagan, Andrew Hamilton, Bruce Pitt, Saïd M. Sebti, Paul Davies

Research output: Contribution to journalArticle

Abstract

We recently showed that the farnesyltransferase inhibitor FTI-277 blocks interleukin 1β (IL-1β)-induced nitric oxide production in pulmonary vascular smooth muscle cells (SMC), whereas the geranylgeranyltransferase inhibitor GGTI-298 enhances this effect. Here we show that IL-1β and platelet-derived growth factor (PDGF) stimulate superoxide production by pulmonary vascular SMC and that this effect is blocked by both FTI-277 and GGTI-298, suggesting that farnesylated and geranylgeranylated proteins are required for superoxide production. We also show that FTI-277 and GGTI-298 block superoxide production stimulated by constitutively active mutant H- Ras. Furthermore, superoxide production by IL-1β, PDGF factor, and constitutively activated Ras is blocked by diphenyleneiodonium, implicating NAD(P)H oxidase as the generating enzyme. Given the role of oxidant radicals in vascular reactivity and injury, the action of both FTI-277 and GGTI-298 in suppressing superoxide generation by an inflammatory cytokine as well as by a potent smooth muscle mitogen may be therapeutically useful.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume278
Issue number2 22-2
StatePublished - Feb 2000

Fingerprint

Dimethylallyltranstransferase
Vascular Smooth Muscle
Superoxides
Lung
Interleukin-1
Platelet-Derived Growth Factor
Smooth Muscle Myocytes
Farnesyltranstransferase
NADPH Oxidase
Vascular System Injuries
Mitogens
Oxidants
Smooth Muscle
Nitric Oxide
Cytokines
GGTI 298
FTI 277
Enzymes
Proteins

Keywords

  • Farnesyltransferase
  • Geranylgeranyltransferase
  • Interleukin-β
  • Platelet-derived growth factor
  • Ras

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology
  • Physiology (medical)

Cite this

Boota, A., Johnson, B., Lee, K. L., Blaskovich, M. A., Liu, S. X., Kagan, V. E., ... Davies, P. (2000). Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle. American Journal of Physiology - Lung Cellular and Molecular Physiology, 278(2 22-2).

Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle. / Boota, Ahmad; Johnson, Bruce; Lee, Kee L.; Blaskovich, Michelle A.; Liu, Shang Xi; Kagan, Valerian E.; Hamilton, Andrew; Pitt, Bruce; Sebti, Saïd M.; Davies, Paul.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 278, No. 2 22-2, 02.2000.

Research output: Contribution to journalArticle

Boota, A, Johnson, B, Lee, KL, Blaskovich, MA, Liu, SX, Kagan, VE, Hamilton, A, Pitt, B, Sebti, SM & Davies, P 2000, 'Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle', American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 278, no. 2 22-2.
Boota, Ahmad ; Johnson, Bruce ; Lee, Kee L. ; Blaskovich, Michelle A. ; Liu, Shang Xi ; Kagan, Valerian E. ; Hamilton, Andrew ; Pitt, Bruce ; Sebti, Saïd M. ; Davies, Paul. / Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2000 ; Vol. 278, No. 2 22-2.
@article{438b46a20f7f4f3a81c0e350e45467a3,
title = "Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle",
abstract = "We recently showed that the farnesyltransferase inhibitor FTI-277 blocks interleukin 1β (IL-1β)-induced nitric oxide production in pulmonary vascular smooth muscle cells (SMC), whereas the geranylgeranyltransferase inhibitor GGTI-298 enhances this effect. Here we show that IL-1β and platelet-derived growth factor (PDGF) stimulate superoxide production by pulmonary vascular SMC and that this effect is blocked by both FTI-277 and GGTI-298, suggesting that farnesylated and geranylgeranylated proteins are required for superoxide production. We also show that FTI-277 and GGTI-298 block superoxide production stimulated by constitutively active mutant H- Ras. Furthermore, superoxide production by IL-1β, PDGF factor, and constitutively activated Ras is blocked by diphenyleneiodonium, implicating NAD(P)H oxidase as the generating enzyme. Given the role of oxidant radicals in vascular reactivity and injury, the action of both FTI-277 and GGTI-298 in suppressing superoxide generation by an inflammatory cytokine as well as by a potent smooth muscle mitogen may be therapeutically useful.",
keywords = "Farnesyltransferase, Geranylgeranyltransferase, Interleukin-β, Platelet-derived growth factor, Ras",
author = "Ahmad Boota and Bruce Johnson and Lee, {Kee L.} and Blaskovich, {Michelle A.} and Liu, {Shang Xi} and Kagan, {Valerian E.} and Andrew Hamilton and Bruce Pitt and Sebti, {Sa{\"i}d M.} and Paul Davies",
year = "2000",
month = "2",
language = "English (US)",
volume = "278",
journal = "American Journal of Physiology - Lung Cellular and Molecular Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "2 22-2",

}

TY - JOUR

T1 - Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle

AU - Boota, Ahmad

AU - Johnson, Bruce

AU - Lee, Kee L.

AU - Blaskovich, Michelle A.

AU - Liu, Shang Xi

AU - Kagan, Valerian E.

AU - Hamilton, Andrew

AU - Pitt, Bruce

AU - Sebti, Saïd M.

AU - Davies, Paul

PY - 2000/2

Y1 - 2000/2

N2 - We recently showed that the farnesyltransferase inhibitor FTI-277 blocks interleukin 1β (IL-1β)-induced nitric oxide production in pulmonary vascular smooth muscle cells (SMC), whereas the geranylgeranyltransferase inhibitor GGTI-298 enhances this effect. Here we show that IL-1β and platelet-derived growth factor (PDGF) stimulate superoxide production by pulmonary vascular SMC and that this effect is blocked by both FTI-277 and GGTI-298, suggesting that farnesylated and geranylgeranylated proteins are required for superoxide production. We also show that FTI-277 and GGTI-298 block superoxide production stimulated by constitutively active mutant H- Ras. Furthermore, superoxide production by IL-1β, PDGF factor, and constitutively activated Ras is blocked by diphenyleneiodonium, implicating NAD(P)H oxidase as the generating enzyme. Given the role of oxidant radicals in vascular reactivity and injury, the action of both FTI-277 and GGTI-298 in suppressing superoxide generation by an inflammatory cytokine as well as by a potent smooth muscle mitogen may be therapeutically useful.

AB - We recently showed that the farnesyltransferase inhibitor FTI-277 blocks interleukin 1β (IL-1β)-induced nitric oxide production in pulmonary vascular smooth muscle cells (SMC), whereas the geranylgeranyltransferase inhibitor GGTI-298 enhances this effect. Here we show that IL-1β and platelet-derived growth factor (PDGF) stimulate superoxide production by pulmonary vascular SMC and that this effect is blocked by both FTI-277 and GGTI-298, suggesting that farnesylated and geranylgeranylated proteins are required for superoxide production. We also show that FTI-277 and GGTI-298 block superoxide production stimulated by constitutively active mutant H- Ras. Furthermore, superoxide production by IL-1β, PDGF factor, and constitutively activated Ras is blocked by diphenyleneiodonium, implicating NAD(P)H oxidase as the generating enzyme. Given the role of oxidant radicals in vascular reactivity and injury, the action of both FTI-277 and GGTI-298 in suppressing superoxide generation by an inflammatory cytokine as well as by a potent smooth muscle mitogen may be therapeutically useful.

KW - Farnesyltransferase

KW - Geranylgeranyltransferase

KW - Interleukin-β

KW - Platelet-derived growth factor

KW - Ras

UR - http://www.scopus.com/inward/record.url?scp=0034011189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034011189&partnerID=8YFLogxK

M3 - Article

C2 - 10666117

AN - SCOPUS:0034011189

VL - 278

JO - American Journal of Physiology - Lung Cellular and Molecular Physiology

JF - American Journal of Physiology - Lung Cellular and Molecular Physiology

SN - 1040-0605

IS - 2 22-2

ER -